Many of you have been following us for a long time on Croblanc, and you already know that we regularly share new video content from the Youtube channel Bloomberg Television which our community is extremely fond of. We think you'll find this video interesting, so we decided to make this post today.
The Youtube channel Bloomberg Television has published today a new video called Novo Nordisk CEO on Catalent, Ozempic and Wegovy. You want to discover this video and watch it in streaming, you are lucky we put it aside for you!
Many people have been talking about this new video for several hours on social networks and it has also generated many comments on the forums found on the web. Moreover, the Youtube channel Bloomberg Television is not new to publishing a video that is causing a stir. We know that you are often very interested in this type of content.
Do you have a problem with this video? Or did you see a small error in the content you just watched? That's why Youtube has set up an "About" section that will allow you to contact all your favorite youtubers and all the channels you need. In case you can't reach the channel you want, you can still use social networks such as twitter where it's very easy to send a message to bring up an information.
You now have all the information about the video Novo Nordisk CEO on Catalent, Ozempic and Wegovy, we hope you like it and that you found it interesting. Have you already watched the whole video? Don't forget to check our site for other content related to Bloomberg Television, we have a lot of it available and new videos are coming very soon, trust us!
Looking forward to discovering new contents with you, see you next time on Croblanc!
For your information, you can find below the description of the video Novo Nordisk CEO on Catalent, Ozempic and Wegovy published by the Youtube channel Bloomberg Television:
Novo Nordisk A/S CEO Lars Fruergaard Jorgensen discusses the company's acquisition of Catalent for for $16.5 billion and the production of its weight-loss drug Wegovy and diabetes treatment Ozempic.
For more on this story, please see: https://www.bloomberg.com/news/articles/2024-02-05/novo-nordisk-spends-11-billion-on-meeting-obesity-drug-demand
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on...